Regarding insulin resistance and diabetes, metformin induces a rapid anxiolytic effect, activates AMPK, up-regulates FoxO3a protein and GABAA receptors expression and increases miniature inhibitory postsynaptic currents (Fan et al., 2018; Ji et al., 2019). Here, PRKAA2 is linked to diabetes mellitus.